Prestige Brands Holdings, Inc. to Release Fiscal 2013 Third Quarter Earnings on February 7th
Prestige Brands Holdings, Inc. (NYSE: PBH) today announced that it will
issue its fiscal 2013 third quarter earnings release on Thursday,
February 7, 2013 before the opening of the market. The Company will host
a conference call to discuss the results that same morning at 8:30 a.m.
EST.
To access the call, listeners calling from within North America may dial
866-578-5788 about 15 minutes prior to the start of the call. Those
wishing to access the call from outside North America should dial
617-213-8057. The conference pass code is “prestige”. The Company will
provide a live internet web cast as well as an archived replay, which
can be accessed from the Investor Relations page of http://prestigebrands.com.
Telephonic replays will be available for two weeks following completion
of the live call and can be accessed at 888-286-8010 within North
America, and at 617-801-6888 from outside North America. The pass code
is 31315331.
Prestige Brands markets and distributes brand name over-the-counter
healthcare and household products throughout the United States, Canada
and certain international markets. Core brands include Chloraseptic®
sore throat treatments, Compound W® wart treatments, Clear
Eyes® eye care products, Little Remedies® and
PediaCare® pediatric over-the-counter healthcare products,
The Doctor’s® NightGuard® dental protector, Efferdent®
denture care products, Luden’s® throat drops, Dramamine®
motion sickness treatment, BC® and Goody’s®
headache remedies, Beano® gas prevention, Debrox®
earwax remover, and Gaviscon® antacid.